Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. NVCN

Healthcare Medical Instruments & Supplies
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

Neovasc Inc. > The split is on the table
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by Barewoodon May 24, 2018 1:40pm
250 Views
Post# 28076348

RE:RE:RE:The split is on the table

RE:RE:RE:The split is on the tableThe major point here is, and if you look through and or listen to the updates provided by the Company, if Neovasc does not meet the NASDAQ's minimum pps of $1.00, the Company stands the risk of being delisted, which means Neovasc will not have access to major institutional investors. The Goal hear is to bring it two key products to the U.S.. Read the following and you'll see: News Release
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities